Genscript Biotech Corp. | Mutual Funds
Mutual Funds that own Genscript Biotech Corp.
Vanguard Emerging Markets Stock Index Fund
11,248,825
0.61%
-140,000
0.03%
07/31/2018
Vanguard Total International Stock Index Fund
10,276,198
0.56%
0
0.01%
07/31/2018
iShares Core MSCI Emerging Markets ETF
6,824,000
0.37%
0
0.03%
09/05/2018
Fisher Invts. Instl. Funds Plc - Emerging Markets Equity
5,630,000
0.31%
0
0.52%
06/30/2018
iShares MSCI Emerging Markets ETF
4,708,000
0.26%
0
0.03%
09/06/2018
Matthews Asia Growth Fund
4,302,000
0.23%
1,092,000
0.82%
06/29/2018
Matthews Asia Small Companies Fund
1,708,000
0.09%
-54,000
1%
06/29/2018
iShares MSCI China ETF
1,698,000
0.09%
0
0.11%
09/06/2018
Vanguard Investment Series Plc - Emerging Markets Stock Index
1,458,000
0.08%
1,458,000
0.03%
07/31/2018
AP7 Aktiefond
1,390,000
0.08%
1,390,000
0.01%
06/29/2018
| Address |
No. 28, Yongxi Road
Nanjing Jiangsu 210000
China
|
|
Employees
|
- |
| Website |
http://www.genscript.com |
| Updated |
07/08/2019 |
| Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. It operates through the following segments: Bio-science Services and Products; Precision Immune-cell Therapy; and Industrial Synthetic Biology Products. The Bio-science Services and Products segment includes life sciences research services, life sciences research catalogue products, and preclinical drug development services. |
